One notable characteristic of the launch readiness landscape as we settle into 2020 is the lower volume of innovative drugs entering the marketplace. The record number of approvals granted in 2018 by the two most influential agencies, the US Food and Drug Administration and the European Medicines Agency, did not hold up in 2019.
Topics: Pharma launch planning, Pharma trends, Market access, launch readiness, Tender Management
For all its reliance on innovation as a business driver, pharmaceuticals is a traditionally conservative industry that advances by small and careful steps. As we map out some of the dominant pharma trends for 2020, perhaps we should also reflect on what ‘innovation’ actually means, what its value is, and what it costs.
Topics: Pharma launch planning, Pharma trends, Market access, launch readiness, Tender Management, #2019 Pharma Trends
As we inch warily or rush enthusiastically into another year against a backdrop of political turmoil and business uncertainty in major markets, it is time to look at the prevailing 2019 pharmaceutical industry trends and what they might mean for companies launching new medicines, negotiating market access barriers, or simply trying to do what they do better. Inevitably, the US is in the thick of the action. But there are many other important 2019 pharma trends, both national and global, that will set the pace for industry throughout what promises to be another dynamic and challenging year.
Topics: Pharma launch planning, Pharma trends, Market access, launch readiness, Tender Management, #2019 Pharma Trends
What does 2018 have in store for the pharmaceutical and biotech industry? In our new '6 Pharma Trends for 2018 Infographic' we look at the key trends that we believe will shape the operating environment for the industry over the year ahead.
Topics: Pharma launch planning, Pharma trends, Market access, 2018 trends, 2018 pharma trends, infograph
The pharmaceutical market is always challenging, and 2017 has been no exception. As we look ahead to some key pharma trends for 2018, we find certain hardy perennials, such as drug pricing, that re-emerge in new iterations year after year.
Topics: Pharma launch planning, Pharma trends, Market access, 2018 trends, 2018 pharma trends